Clinical Trials

60 enrolled

Prostatic Neoplasms

NCT04215029 2026-04-15

Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans

6 enrolled

Prostatic Neoplasms

NCT04396808 2026-04-15

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

805 enrolled

Phase EARLY_PHASE1 Active not recruiting

Prostatic Neoplasms

NCT05047965 2026-04-15

An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

65 enrolled

Prostatic Neoplasms

NCT05055843 2026-04-15

Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer

33 enrolled

Prostatic Neoplasms

NCT05960578 2026-04-14

Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

8 enrolled

Prostatic Neoplasms

NCT02346253 2026-04-13

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

146 enrolled

Prostatic Neoplasms

NCT04842890 2026-04-13

Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer

61 enrolled

Prostatic Neoplasms

NCT06434649 2026-04-13

Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer

118 enrolled

Prostatic Neoplasms

NCT04985565 2026-04-09

Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer

12 enrolled

Prostatic Neoplasms

NCT00859781 2026-04-08

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

55 enrolled 11 charts

Prostatic Neoplasms

NCT03827616 2026-04-08

Moderately Hypofractionated Radiotherapy for Prostate Cancer.

400 enrolled

Prostatic Neoplasms

NCT05053152 2026-04-08

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

194 enrolled

Prostatic Neoplasms

NCT06303713 2026-04-08

LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer

37 enrolled

Prostatic Neoplasms

NCT00579514 2026-04-07

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

BreastGastrointestinalGenitourinaryGynecologicThoracic

21,081 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT05079698 2026-04-07

A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

29 enrolled

Prostatic Neoplasms

NCT04709276 2026-04-06

CHAMP

41 enrolled

Prostatic Neoplasms

NCT04147806 2026-04-03

PROSINT

31 enrolled

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT04513717 2026-04-03

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

2,753 enrolled

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT03543189 2026-04-01

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

44 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT04300855 2026-04-01

Clinical Trial of Green Tea Catechins in Men on Active Surveillance

115 enrolled

Prostatic Neoplasms

NCT06734130 2026-04-01

Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer

25 enrolled

Prostatic Neoplasms

NCT04357925 2026-03-31

QoLProstateMQ

304 enrolled

Prostatic Neoplasms

NCT04886986 2026-03-31

Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer

20 enrolled

Prostatic Neoplasms

NCT05266313 2026-03-31

VITALITE

135 enrolled

Prostatic Neoplasms

NCT03471650 2026-03-30

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

150 enrolled

Prostatic Neoplasms

NCT03436654 2026-03-27

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

102 enrolled

Prostatic Neoplasms

NCT05826509 2026-03-27

SUGAR

240 enrolled

Prostatic Neoplasms

NCT05345444 2026-03-25

RTIRE

48 enrolled

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT05678322 2026-03-25

Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

26 enrolled 7 charts

Prostatic Neoplasms

NCT04905082 2026-03-24

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

BreastGastrointestinalGenitourinaryGynecologicThoracic

465 enrolled 11 charts

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT01441687 2026-03-23

Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome

243 enrolled

Prostatic Neoplasms

NCT02722525 2026-03-23

Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer

23 enrolled

Prostatic Neoplasms

NCT03787680 2026-03-23

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

49 enrolled 11 charts

Prostatic Neoplasms

NCT04879940 2026-03-23

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

17 enrolled

Prostatic Hyperplasia, Prostatic Neoplasms

NCT05096338 2026-03-23

PCT

200 enrolled

Cardiovascular Diseases, Prostatic Neoplasms, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

NCT07462403 2026-03-23

A mLifestyle Intervention for Men on Androgen Deprivation Therapy for PCa

45 enrolled

Phase EARLY_PHASE1 Active not recruiting

Prostatic Neoplasms

NCT05477823 2026-03-20

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT06018311 2026-03-20

HACER

58 enrolled

Caregiver Burden, Motor Activity, Neoplasms, Prostatic Neoplasms

NCT06126172 2026-03-20

Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions

125 enrolled

Prostatic Neoplasms, Recurrence

NCT03412396 2026-03-19

Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy

45 enrolled 10 charts

Prostatic Neoplasms

NCT04262609 2026-03-19

Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy

200 enrolled

Encopresis, Prostatic Neoplasms

NCT06964412 2026-03-19

The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate Brachytherapy

36 enrolled

Prostatic Neoplasms

NCT03663218 2026-03-18

PREPARE SBRT

16 enrolled 9 charts

Prostatic Neoplasms

NCT05343936 2026-03-18

Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population

490 enrolled

Prostatic Neoplasms

NCT06307704 2026-03-18

Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients

88 enrolled

Urinary Bladder Neoplasms, Prostatic Neoplasms

NCT06408597 2026-03-18

Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy

90 enrolled

Urinary Bladder Neoplasms, Prostatic Neoplasms, Renal Insufficiency, Acute Kidney Injury

NCT05245006 2026-03-17

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

30 enrolled

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT07477626 2026-03-17

RADVAN

374 enrolled

Prostatic Neoplasms

NCT04190446 2026-03-16

A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

84 enrolled